OPA1 and myeloid sarcoma: This protein is able to reduce neuroinflammation and to promote neural repair in the experimental autoimmune encephalomyelitis (EAE) model of MS, through a general decrease in proinflammatory cytokine and chemokine secretion, and a downregulation of proapoptotic factors and of activating and migrating proteins such as OPA1 [144].